<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-5071</title>
	</head>
	<body>
		<main>
			<p>930605 FT  05 JUN 93 / Finance and the Family: Market frets over Boots - At a glance BOOTS announced a 19 per cent increase in pre-tax profits, but its shares have underperformed the market by almost 25 per cent since January. The share price has been knocked by City fears that the group's strategy in the face of price competition from rivals such as Superdrug could threaten margins at Boots the Chemist, and that problems with the US authorities over Manoplax, a heart drug, could cut profits at Boots Pharmaceuticals.</p>
		</main>
</body></html>
            